跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRUVADA tenofovir disoproxil fumarate / emtricitabine 300/200 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
TRUVADA tenofovir disoproxil fumarate / emtricitabine 300/200 mg tablet bottle
Approved
STANDARD
TRUVADA tenofovir disoproxil fumarate / emtricitabine 300/200 mg tablet bottle
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
3711ae9336146fd8
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
3711ae9336146fd8
Product Name
TRUVADA tenofovir disoproxil fumarate / emtricitabine 300/200 mg tablet bottle
Artg Id
107072
Artg Name
TRUVADA tenofovir disoproxil fumarate / emtricitabine 300/200 mg tablet bottle
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2005-09-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ba8514117c9c220e2c1eef2a3696a866.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b2f44323732bc936338a06340e738519.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
3711ae9336146fd8
Type
Standard
Back to TGA Approvals